Custom Synthesis

Ecotoxicology

Environmental fate

Induced Disease Models

In vitro techniques

Toxicology

Metabolism Identification

Stability Testing

Pharmacokinetics and Metabolism

Regulatory Affairs

Residue Studies

Target Animal Safety

Veterinary Clinical Trials

Support Services

Toxicology Consultancy

 

Environmental Risk Assessments for Fish Medicines

For fish medicines where direct entry into the aquatic environment is intended, Phase II Tier A studies are always required unless the environmental introduction concentration (EIC) is 1mg/l or less. The basic data needed are:

  • Octanol / water partition coefficient
  • Rate of hydrolysis
  • Rate of photodegradation in water
  • Basic ecotoxicology data in fresh water and / or marine species according to proposed use

If the EIC is greater than the predicted no effect concentration (PNEC) or the DT50 of the VMP in water is greater than 4 days, then further work is needed. This would include a water / sediment degradation study under fresh water or marine conditions (OECD 308) and assessment of the toxicity to additional aquatic or sediment-dwelling species.